Clinical Trials

Stop Children’s Cancer is in the fifth year of a seven-year pledge of $1.05 million to clinical trials research to find cures for the most high-risk pediatric cancer patients. With this donation the University of Florida Department of Pediatrics has been able to increase the number of children who can participate in this vital, life-saving research.

Under Pediatric Clinical Trials Director Gigi Moore-Higgs, 19 new clinical trials have opened including 3 Phase 1 trials for children with recurrent disease who have very few options for treatment.  In addition, several supportive care trials to find better treatment for chemotherapy related side effects have begun, and the department has partnered with pharmaceutical companies to broaden the trial portfolio.  Faculty members have submitted a number of new grants to support investigator-initiated clinical trials and have been successful with one study scheduled to open in the Fall 2013.

Currently only about 4% of federal research dollars go to pediatric cancer research. Other research funding from private groups and pharmaceutical companies is overwhelmingly directed to adult cancers. This Stop Children’s Cancer funding, directed specifically to children’s cancer, fills a critical need.

Your support makes a difference!